Crescita Therapeutics Inc - Asset Resilience Ratio

Latest as of September 2025: 38.72%

Crescita Therapeutics Inc (CTX) has an Asset Resilience Ratio of 38.72% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read CTX total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CA$8.31 Million

≈ $6.01 Million USD Cash + Short-term Investments

Total Assets

CA$21.46 Million

≈ $15.52 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Crescita Therapeutics Inc's Asset Resilience Ratio has changed over time. See CTX net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Crescita Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Crescita Therapeutics Inc market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$8.31 Million	38.72%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$8.31 Million	38.72%

Asset Resilience Insights

Very High Liquidity: Crescita Therapeutics Inc maintains exceptional liquid asset reserves at 38.72% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Crescita Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Crescita Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Crescita Therapeutics Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Crescita Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	42.58%	CA$9.27 Million ≈ $6.71 Million	CA$21.78 Million ≈ $15.75 Million	+4.42pp
2023-12-31	38.17%	CA$9.39 Million ≈ $6.79 Million	CA$24.60 Million ≈ $17.79 Million	+8.99pp
2022-12-31	29.17%	CA$8.31 Million ≈ $6.01 Million	CA$28.48 Million ≈ $20.60 Million	-10.28pp
2021-12-31	39.45%	CA$11.41 Million ≈ $8.25 Million	CA$28.92 Million ≈ $20.92 Million	-14.00pp
2020-12-31	53.45%	CA$14.34 Million ≈ $10.37 Million	CA$26.83 Million ≈ $19.41 Million	+18.69pp
2019-12-31	34.76%	CA$9.33 Million ≈ $6.75 Million	CA$26.84 Million ≈ $19.41 Million	+3.42pp
2018-12-31	31.34%	CA$8.64 Million ≈ $6.25 Million	CA$27.57 Million ≈ $19.94 Million	+0.07pp
2017-12-31	31.28%	CA$7.06 Million ≈ $5.11 Million	CA$22.57 Million ≈ $16.32 Million	-11.40pp
2016-12-31	42.68%	CA$18.36 Million ≈ $13.28 Million	CA$43.02 Million ≈ $31.12 Million	+42.51pp
2015-12-31	0.17%	CA$2.00K ≈ $1.45K	CA$1.19 Million ≈ $859.38K	+0.05pp
2014-12-31	0.12%	CA$2.00K ≈ $1.45K	CA$1.64 Million ≈ $1.18 Million	--

pp = percentage points

About Crescita Therapeutics Inc

TO:CTX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$10.23 Million

CA$14.15 Million CAD

Market Cap Rank

#26834 Global

#1136 in Canada

Share Price

CA$0.76

Change (1 day)

+1.33%

52-Week Range

CA$0.42 - CA$0.76

All Time High

CA$1.82